Clinical trials
Phase 1 Carcinoma, Renal Cell trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 3 |
| Recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Exelixis | 3 |
| Amgen | 1 |
| Bristol-Myers Squibb | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Hoffmann-La Roche | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Kura Oncology, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Renal Cell | 16 |
| Colorectal Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Neoplasms | 6 |
| Kidney Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 5 |
| Carcinoma, Transitional Cell | 3 |
| Head and Neck Neoplasms | 3 |
| Ovarian Neoplasms | 3 |
| Triple Negative Breast Neoplasms | 3 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.